Physician-scientist with a specialization in Endocrinology. Currently, Staff Scientist at the Hermelin Brain Tumor Center (HBTC), Department of Neurosurgery, Henry Ford Health, Detroit, MI, USA. Assistant Professor-Research appointment at the Department of Physiology, Michigan State University, E. Lansing, MI , USA. Over 25 years of experience in medical practice and teaching at prestigious universities in Brazil,. Academic training and research experience in molecular biology, oncology, (epi)genetics, human physiology and diseases and bioinformatics. Recently, leads a team working on projects to understand the biological and clinical significance of DNA methylation and other epigenetic mechanism in CNS tumors development and progression, including pituitary tumors and other sellar and CNS entities, using invasive (tissue) and noninvasive (liquid biopsy) approaches. Main research objectives are to identify diagnostic and prognostic markers and potential drug targets that can personalize the management and treatment of patients with CNS tumors.